Merck Global Health Innovation Fund (MGHIF) is a growth investor partnering with innovative digital health and data science companies that facilitate and optimize biopharmaceutical operations with the goal of improving patient care.

Founded in 1988, FFF Enterprises, Inc. is a privately held, multibillion-dollar specialty pharmaceutical distributor and diversified healthcare company. FFF Enterprises is the parent company to leading specialty pharmacy Nufactor, Inc., as well as InCircle, LLC and RightNow Inventory™. Our partners include global pharmaceutical and biologics manufacturers, prestigious healthcare systems, large and independent retail pharmacies, and leading alternate care sites. Our nationwide commerce is supported by a network of distribution and infusion pharmacy locations utilizing world-class technology and cybersecurity solutions.

IMC is the global leader in smart medication adherence solutions, having supplied over a million units to the clinical trials and research markets. IMC manufactures iOS and Android NFC-certified Med-ic Smart Blister Packages, eCAP Smart Medication Bottles and the temperature-aware Med-ic Smart Syringe Pack. IMC is active in the AI-enabled digital health field, offering its HIPAA compliant, secure CertiScan clinical research adherence cloud. IMC’s latest Lilipond AI project is aimed at detecting opiate abuse early to avoid dependence and addiction.

We are in the business of building authentic, long-term relationships with our clients, who are some of the world’s most successful and innovative investors, entrepreneurs and disruptors at the convergence of and within the life sciences, private equity, real estate, technology and financial industries. Our immersive understanding of these industries — combined with our expertise across high-stakes litigation and dispute resolution, world-class regulatory compliance and advisory services, and complex transactions — sets us apart. To learn more about our global law firm, please visit www.goodwinlaw.com.